Literature DB >> 22547678

IκB kinase α phosphorylation of TRAF4 downregulates innate immune signaling.

Jill M Marinis1, Jessica E Hutti, Craig R Homer, Brian A Cobb, Lewis C Cantley, Christine McDonald, Derek W Abbott.   

Abstract

Despite their homology, IκB kinase α (IKKα) and IKKβ have divergent roles in NF-κB signaling. IKKβ strongly activates NF-κB while IKKα can downregulate NF-κB under certain circumstances. Given this, identifying independent substrates for these kinases could help delineate their divergent roles. Peptide substrate array technology followed by bioinformatic screening identified TRAF4 as a substrate for IKKα. Like IKKα, TRAF4 is atypical within its family because it is the only TRAF family member to negatively regulate innate immune signaling. IKKα's phosphorylation of serine-426 on TRAF4 was required for this negative regulation. Binding to the Crohn's disease susceptibility protein, NOD2, is required for TRAF4 phosphorylation and subsequent inhibition of NOD2 signaling. Structurally, serine-426 resides within an exaggerated β-bulge in TRAF4 that is not present in the other TRAF proteins, and phosphorylation of this site provides a structural basis for the atypical function of TRAF4 and its atypical role in NOD2 signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547678      PMCID: PMC3434482          DOI: 10.1128/MCB.00106-12

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  53 in total

Review 1.  Missing pieces in the NF-kappaB puzzle.

Authors:  Sankar Ghosh; Michael Karin
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.

Authors:  Xiaoming Li; Yili Yang; Jonathan D Ashwell
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

3.  CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells.

Authors:  Tadakazu Hisamatsu; Manabu Suzuki; Hans-Christian Reinecker; William J Nadeau; Beth A McCormick; Daniel K Podolsky
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

4.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

5.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

6.  RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.

Authors:  Koichi Kobayashi; Naohiro Inohara; Lorraine D Hernandez; Jorge E Galán; Gabriel Núñez; Charles A Janeway; Ruslan Medzhitov; Richard A Flavell
Journal:  Nature       Date:  2002-03-14       Impact factor: 49.962

7.  IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a.

Authors:  Mickey C-T Hu; Dung-Fang Lee; Weiya Xia; Leonard S Golfman; Fu Ou-Yang; Jer-Yen Yang; Yiyu Zou; Shilai Bao; Norihisa Hanada; Hitomi Saso; Ryuji Kobayashi; Mien-Chie Hung
Journal:  Cell       Date:  2004-04-16       Impact factor: 41.582

8.  Distinct molecular mechanism for initiating TRAF6 signalling.

Authors:  Hong Ye; Joseph R Arron; Betty Lamothe; Maurizio Cirilli; Takashi Kobayashi; Nirupama K Shevde; Deena Segal; Oki K Dzivenu; Masha Vologodskaia; Mijung Yim; Khoi Du; Sujay Singh; J Wesley Pike; Bryant G Darnay; Yongwon Choi; Hao Wu
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

9.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

Review 10.  The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes.

Authors:  Asma Smahi; Gilles Courtois; Smail Hadj Rabia; Rainer Döffinger; Christine Bodemer; Arnold Munnich; Jean-Laurent Casanova; Alain Israël
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

View more
  20 in total

Review 1.  Emerging significance of NLRs in inflammatory bowel disease.

Authors:  Beckley K Davis; Casandra Philipson; Raquel Hontecillas; Kristin Eden; Josep Bassaganya-Riera; Irving C Allen
Journal:  Inflamm Bowel Dis       Date:  2014-12       Impact factor: 5.325

2.  Cytosolic DNA Promotes Signal Transducer and Activator of Transcription 3 (STAT3) Phosphorylation by TANK-binding Kinase 1 (TBK1) to Restrain STAT3 Activity.

Authors:  Hung-Ching Hsia; Jessica E Hutti; Albert S Baldwin
Journal:  J Biol Chem       Date:  2017-02-10       Impact factor: 5.157

3.  Cytosolic-DNA-mediated, STING-dependent proinflammatory gene induction necessitates canonical NF-κB activation through TBK1.

Authors:  Takayuki Abe; Glen N Barber
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

Review 4.  Recent progress using systems biology approaches to better understand molecular mechanisms of immunity.

Authors:  Rachel A Gottschalk; Andrew J Martins; Virginie Sjoelund; Bastian R Angermann; Bin Lin; Ronald N Germain
Journal:  Semin Immunol       Date:  2012-12-11       Impact factor: 11.130

Review 5.  RIP2 activity in inflammatory disease and implications for novel therapeutics.

Authors:  Janice C Jun; Fabio Cominelli; Derek W Abbott
Journal:  J Leukoc Biol       Date:  2013-06-21       Impact factor: 4.962

6.  TRAF4 is a critical molecule for Akt activation in lung cancer.

Authors:  Wei Li; Cong Peng; Mee-Hyun Lee; DoYoung Lim; Feng Zhu; Yang Fu; Ge Yang; Yuqiao Sheng; Lanbo Xiao; Xin Dong; WeiYa Ma; Ann M Bode; Ya Cao; Zigang Dong
Journal:  Cancer Res       Date:  2013-10-23       Impact factor: 12.701

7.  An IκB Kinase-Regulated Feedforward Circuit Prolongs Inflammation.

Authors:  Jessica M Perez; Steven M Chirieleison; Derek W Abbott
Journal:  Cell Rep       Date:  2015-07-16       Impact factor: 9.423

8.  Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα).

Authors:  Han C Dan; Aaron Ebbs; Manolis Pasparakis; Terry Van Dyke; Daniela S Basseres; Albert S Baldwin
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

9.  Structural biology study of human TNF receptor associated factor 4 TRAF domain.

Authors:  Fengfeng Niu; Heng Ru; Wei Ding; Songying Ouyang; Zhi-Jie Liu
Journal:  Protein Cell       Date:  2013-08-27       Impact factor: 14.870

10.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.